119 related articles for article (PubMed ID: 38754536)
1. Oridonin, a small molecule inhibitor of cancer stem cell with potent cytotoxicity and differentiation potential.
Li Y; Xie J; Du X; Chen Y; Wang C; Liu T; Yi Z; Wang Y; Zhao M; Li X; Shi S
Eur J Pharmacol; 2024 Jul; 975():176656. PubMed ID: 38754536
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis inducing and differentiation enhancement effect of oridonin on the all-trans-retinoic acid-sensitive and -resistant acute promyelocytic leukemia cells.
Gao F; Tang Q; Yang P; Fang Y; Li W; Wu Y
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e114-22. PubMed ID: 19302235
[TBL] [Abstract][Full Text] [Related]
3. Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects.
Li J; Wu Y; Wang D; Zou L; Fu C; Zhang J; Leung GP
Pharmacol Res; 2019 Aug; 146():104313. PubMed ID: 31202781
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling.
Liu RX; Ma Y; Hu XL; Ren WY; Liao YP; Wang H; Zhu JH; Wu K; He BC; Sun WJ
Int J Oncol; 2018 Nov; 53(5):2091-2101. PubMed ID: 30132514
[TBL] [Abstract][Full Text] [Related]
5. Oridonin induces ferroptosis by inhibiting gamma-glutamyl cycle in TE1 cells.
Zhang J; Wang N; Zhou Y; Wang K; Sun Y; Yan H; Han W; Wang X; Wei B; Ke Y; Xu X
Phytother Res; 2021 Jan; 35(1):494-503. PubMed ID: 32869425
[TBL] [Abstract][Full Text] [Related]
6. Oridonin up-regulates expression of P21 and induces autophagy and apoptosis in human prostate cancer cells.
Li X; Li X; Wang J; Ye Z; Li JC
Int J Biol Sci; 2012; 8(6):901-12. PubMed ID: 22745580
[TBL] [Abstract][Full Text] [Related]
7. Oridonin promotes RSL3-induced ferroptosis in breast cancer cells by regulating the oxidative stress signaling pathway JNK/Nrf2/HO-1.
Ye S; Hu X; Sun S; Su B; Cai J; Jiang J
Eur J Pharmacol; 2024 Jul; 974():176620. PubMed ID: 38685305
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic effect of oridonin on NB4 cells and its mechanism.
Liu J; Huang R; Lin D; Wu X; Peng J; Lin Q; Pan X; Zhang M; Hou M; Chen F
Leuk Lymphoma; 2005 Apr; 46(4):593-7. PubMed ID: 16019488
[TBL] [Abstract][Full Text] [Related]
9. Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice.
Lou H; Gao L; Wei X; Zhang Z; Zheng D; Zhang D; Zhang X; Li Y; Zhang Q
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):319-25. PubMed ID: 21676599
[TBL] [Abstract][Full Text] [Related]
10. Oridonin upregulates PTEN through activating p38 MAPK and inhibits proliferation in human colon cancer cells.
Wu QX; Yuan SX; Ren CM; Yu Y; Sun WJ; He BC; Wu K
Oncol Rep; 2016 Jun; 35(6):3341-8. PubMed ID: 27108927
[TBL] [Abstract][Full Text] [Related]
11. Selective synergistic anticancer effects of cisplatin and oridonin against human p53-mutant esophageal squamous carcinoma cells.
Yang H; Wang J; Khan S; Zhang Y; Zhu K; Zhou E; Gong M; Liu B; Kan Q; Zhang Q
Anticancer Drugs; 2022 Jan; 33(1):e444-e452. PubMed ID: 34520434
[TBL] [Abstract][Full Text] [Related]
12. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
[TBL] [Abstract][Full Text] [Related]
13. Oridonin inhibits the proliferation of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.
Liu Y; Liu YZ; Zhang RX; Wang X; Meng ZJ; Huang J; Wu K; Luo JY; Zuo GW; Chen L; Yin LJ; Deng ZL; He BC
Int J Oncol; 2014 Aug; 45(2):795-803. PubMed ID: 24859848
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma.
Xu ZZ; Fu WB; Jin Z; Guo P; Wang WF; Li JM
Leuk Lymphoma; 2016; 57(4):888-98. PubMed ID: 26415087
[TBL] [Abstract][Full Text] [Related]
15. 2-Ethoxystypandrone, a novel small-molecule STAT3 signaling inhibitor from Polygonum cuspidatum, inhibits cell growth and induces apoptosis of HCC cells and HCC Cancer stem cells.
Li W; Zhang Q; Chen K; Sima Z; Liu J; Yu Q; Liu J
BMC Complement Altern Med; 2019 Feb; 19(1):38. PubMed ID: 30709346
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Microenvironmental Change by B16F10 Melanoma-derived Proteins Induces Cancer Stem-like Cell Properties from NIH3T3 Cells.
Park SY; Lee DG; Jo A; Choi H; Lee JE; Jeong AJ; Leem SH; Jun W; Shim S; Ye SK; Min JK; Chung JW
Sci Rep; 2019 Nov; 9(1):16757. PubMed ID: 31727938
[TBL] [Abstract][Full Text] [Related]
17. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.
Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW
J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235
[TBL] [Abstract][Full Text] [Related]
18. O-Acetyl-GD2 as a Therapeutic Target for Breast Cancer Stem Cells.
Cheng JY; Hung JT; Lin J; Lo FY; Huang JR; Chiou SP; Wang YH; Lin RJ; Wu JC; Yu J; Yu AL
Front Immunol; 2021; 12():791551. PubMed ID: 35046949
[TBL] [Abstract][Full Text] [Related]
19. Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2-p53 Interaction in Mucoepidermoid Carcinoma.
Andrews A; Warner K; Rodriguez-Ramirez C; Pearson AT; Nör F; Zhang Z; Kerk S; Kulkarni A; Helman JI; Brenner JC; Wicha MS; Wang S; Nör JE
Clin Cancer Res; 2019 Mar; 25(5):1588-1600. PubMed ID: 30498096
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of apoptosis and autophagy elicited by combined treatment with oridonin and cetuximab in laryngeal squamous cell carcinoma.
Cao S; Huang Y; Zhang Q; Lu F; Donkor PO; Zhu Y; Qiu F; Kang N
Apoptosis; 2019 Feb; 24(1-2):33-45. PubMed ID: 30430397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
